We are currently only recruiting healthy volunteers and participants for the Autoimmune Liver Disease (AILD) study arm.
We are currently only recruiting healthy volunteers and participants for the Autoimmune Liver Disease (AILD) study arm.
Recruitment of COVID-19 participants into the COVERSCAN study is now discontinued due to oversubscription. We are turning our attention towards conducting all second visits of our enrolled participants, as well as recruiting healthy volunteers and participants for the Autoimmune Liver Disease (AILD) study arm.
Perspectum has launched the first study to map how COVID-19 impacts the health of multiple organs and identify at-risk features for the virus, with detailed cross-sectional imaging and genetic studies.
This study is on the National Institute for Health Research (NIHR) Portfolio
Clinical Trials Identifier: NCT04369807
To determine the prevalence and degree of organ damage in patients recovering from COVID-19 disease, using multi-parametric magnetic resonance imaging (MRI).
- Lungs
- Heart
- Kidney
- Liver
- Pancreas
- Spleen
The study will use outpatient MRI facilities and involve blood tests, basic physical measurements (height, weight, blood pressure) and online questionnaires.
Gemini One
5520 John Smith Dr, Oxford OX4 2LL, United Kingdom
Chenies Mews Imaging Centre
The Roger Williams Building, 69-75 Chenies Mews
London, WC1E 7HX, United Kingdom
Mayo Clinic (Healthcare)
15 Portland Pl, Marylebone, London W1B 1PT, United Kingdom
(Closed for Screening)
This work was supported by the National Consortium of Intelligent Medical Imaging through the Industry Strategy Challenge Fund, Innovate UK Grant 104688
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 719445
Copyright © 2020 Perspectum - All Rights Reserved.
Powered by GoDaddy Website Builder
This website uses cookies. By continuing to use this site, you accept our use of cookies.